Clinical Trial Update: Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer [Phase 1]

View source ↗

Summary

Phase I trial update evaluating safety and tolerability of chemoradiation followed by chemotherapy plus dostarlimab in stage IIIC, node-positive endometrial can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• JEMPERLI (DOSTARLIMAB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Cancer | Phase 1 | Status: RECRUITING